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Cardiovascular effect of epinephrine in endodontic 
microsurgery: a review
Epinephrine is one of the most widely-used vasoconstrictors in dental treatment 
including endodontic microsurgery. However, the systemic safety of epinephrine has 
been in debate for many years because of its potential risk to cause cardiovascular 
complications. The purpose of this review was to assess the cardiovascular effect of 
epinephrine use in endodontic microsurgery. Endodontic microsurgery directly applies 
epinephrine into the bone cavity, and the amount is reported to be much larger 
than other dental surgeries. Moreover, when considering that systemic potency of 
intraosseous application is reported to be comparable to intravenous application, 
the systemic influence of epinephrine could be increased in endodontic microsurgery. 
Besides, pre-existing cardiovascular complications or drug interactions can enhance 
its systemic influence, resulting in increased susceptibility to cardiovascular 
complications. Although clinical studies have not reported significant complications for 
patients without severe systemic complications, many epinephrine-induced emergency 
cases are warning the cardiovascular risk related with pre-existing systemic disease 
or drug interactions. Epinephrine is a dose-sensitive drug, and its hypersensitivity 
reaction can be fatal to patients when it is related to cardiovascular complications. 
Therefore, clinicians should recognize the risk, and the usage of pre-operative patient 
evaluation, dose control and patient monitoring are required to ensure patient’s safety 
during endodontic microsurgery. (Restor Dent Endod 2013;38(4):187-193)
Key words: Cardiovascular diseases; Drug interactions; Endodontic microsurgery; 
Epinephrine; Hemostasis; Vasoconstrictor agents
Introduction
Epinephrine is one of the most widely-used vasoconstrictors in dentistry. 
However, because of the characteristics as a hormone that influences main organs 
simultaneously, it has been argued as a potential risk factor that can cause 
cardiovascular complications. For this reason, many studies have been published to 
evaluate the safety of epinephrine in dental treatment.1-16 However most of them were 
conducted with tooth extraction2-13 and periodontal surgery,14 and there have been only 
few studies for endodontic microsurgery to this date.15,16
Endodontic microsurgery has a unique feature in regard of epinephrine application, 
especially in intra-operative hemostasis. Almost perfect bleeding control is needed for 
proper inspection of the resected root surface and retro-filling of the root-end cavity, 
which are the most important components of endodontic microsurgery.17-19 For this 
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reason, direct application of epinephrine into the bone 
cavity has been commonly selected by many clinicians, 
which has been confirmed as an effective way to ensure 
hemostasis during surgery.17 However, due to additional 
doses of epinephrine and the administration route 
(intraosseous route) that affects the systemic circulation 
more directly than other routes, the systemic influence of 
epinephrine could be increased in endodontic microsurgery, 
resulting in increased susceptibility to the cardiovascular 
complications.15,16,20,21
As the success rate and long-term prognosis of 
endodontic microsurgery is validated, it is becoming a 
standard treatment option in the endodontic field.22-24 It 
is the time to focus on not only the long-term prognosis 
of endodontic microsurgery, but also the systemic safety 
during treatments.
Therefore, the purposes of this review were to assess the 
cardiovascular effect of epinephrine use in endodontic 
microsurgery, and to make clinical suggestions that can 
reduce the risk of epinephrine.
Review
Pharmacology of epinephrine
Epinephrine is one of the principal hormones that affect 
adrenergic receptors of autonomic nervous system.25 It 
modulates various functions of the body simultaneously 
by affecting different subtypes of the adrenergic receptor. 
Epinephrine induces vasoconstriction of the mucosa, 
skin, and internal organs by affecting α1 adrenergic 
receptor, and increases blood glucose level by affecting 
α2 adrenergic receptor. It also influences β1 adrenergic 
receptor to increase cardiac output by changing heart rate 
and contraction force, and it induces vasodilatation of the 
skeletal muscles, liver and relaxation of bronchial smooth 
muscle by affecting β2 receptor.
In the dental field, epinephrine serves as a local 
vasoconstrictor in local anesthetics or gingival retraction 
cords.26,27 And it is also used in endodontic microsurgery 
as a hemostatic agent to control the bleeding in the bone 
cavity.17 In this way, most dentists only use the effect of 
epinephrine to α1 receptor.
On the other hand, epinephrine is being used for various 
purposes in the medical field. It is injected in case of 
acute hypotensive crisis to elevate the blood pressure 
immediately, and it is also administered to induce 
defibrillation in case of cardiac arrest. In acute asthma 
attack, it is inhaled to induce bronchodilation. Epinephrine 
is not just a simple hemostatic agent but a hormone that 
modulates main organs of the body. In this regard, its 
action on β1 adrenergic receptor can cause unsuspected 
cardiovascular complications during dental surgery if we 
are not aware of its nature.
Predisposing risk factors related with epinephrine 
1. Pre-existing Cardiovascular disease
Patients with cardiovascular diseases are increasing 
in dental practices in recent years. Such patients are 
vulnerable to the stress induced by dental treatment, and 
more susceptible to drug side effects compared to healthy 
patients. Therefore, the possibility of medical emergency 
during dental treatment is more likely in these patients.
Cardiovascular complications of epinephrine on patients 
with hypertension have been a concern in dental practice. 
Bader et al. conducted systematic review to identify 
cardiovascular complications in hypertensive patients 
caused by epinephrine contained in anesthetic solutions.1 
373 studies were initially searched, and finally six studies 
of them were analyzed. This revealed that the effect of 
epinephrine was not significant during dental surgery 
in hypertensive patients compared with normotensive 
patients. However, as the author commented, the number 
of subjects was too small and the information about 
predisposing medical diagnoses and medication status was 
restricted. Moreover, analyzed studies were associated with 
tooth extraction and minor dental surgery, not endodontic 
microsurgery.
Meanwhile, it is not difficult to find epinephrine 
emergency cases in patient with pre-existing cardiovascular 
disease. Lee et al. reported occurrence of cardiac arrest 
induced by submucosal injection of epinephrine in a 
patient with variant angina.28 When 1.5% lidocaine with 
1 : 100,000 epinephrine was injected (about 7.5 mL) 
in the nasal mucosa for septoplasty, sudden ventricular 
tachycardia was observed, followed by cardiac arrest. 
Kim et al. also reported two cases that showed acute 
elevation of blood pressure with severe chest tightness 
during endoscopic submucosal dissection after submucosal 
injection of 1 : 100,000 epinephrine.29 One of the cases 
was diagnosed as myocardiac infarction.
2. Drug interactions
1) Non-selective β blocker
Epinephrine induces vasoconstriction on mucosa, skin, 
and internal organs by affecting α1 adrenergic receptor. 
It also induces vasodilatation of skeletal muscle by 
affecting β2 adrenergic receptor at the same time so 
that rapid increase of blood pressure can be prevented. 
However such mechanism can be disturbed by non-
selective β blocker because it blocks the action of β1 and 
β2 adrenergic receptor.30-34 Therefore epinephrine behaves 
as a pure agonist of α adrenergic receptor inducing acute 
hypertensive crisis, followed by reflex bradycardia, and 
cardiac arrest in the worst case when it is administered 
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with non-selective β blocker.35
Foster and Aston reported case series of drug interaction 
between epinephrine and non-selective β blocker.35 When 
0.5 - 1.0% lidocaine or xylocaine with 1 : 100,000 - 1 
: 200,000 epinephrine was subcutaneously injected to 
patients in medication with propranolol for eyelid-plasty 
and facial plasty, there was acute elevation of systolic 
and diastolic blood pressure, and one of the patient 
experienced cardiac arrest.
2) Monoamine oxidase (MAO) inhibitor and tricyclic
    antidepressant
MAO inhibitor and tricyclic antidepressant acts on axon 
terminal and synaptic space where epinephrine is secreted. 
MAO inhibitor blocks MAO from breaking up transmitter 
molecules that epinephrine concentration is increased 
at axon terminal. Tricyclic antidepressant inhibits the 
reuptake of neurotransmitters from synaptic space to axon 
terminal, and also increases epinephrine concentration 
at synaptic space. Therefore, both MAO inhibitor and 
tricyclic antidepressants induce the effect of overdose 
administration of epinephrine.32-34,36,37
Boakes et al. conducted clinical study to evaluate 
drug interaction between epinephrine and tricyclic 
antidepressant in patients taking imipramine 25 mg t.i.d, 
and observed significant elevation of blood pressure in 
experimental group compared to control group.37 In this 
way, he reported clinical synergistic interaction between 
the two drugs.
Intrinsic risk factors of endodontic microsurgery 
related with epinephrine
1. Dose of epinephrine
A small amount of epinephrine is routinely injected 
as a vasoconstrictor with local anesthetic solution for 
conventional dental surgery and the quantity is about 
0.036 - 0.054 mg (Table 1). However, additional amount of 
epinephrine is applicated in endodontic microsurgery for 
hemostasis of access bone cavity.17 Epinephrine contained 
in one Racellet #3 pellet is equivalent to 15.3 amples 
of 2% lidocaine with 1 : 100,000 epinephrine, and total 
epinephrine dose used in endodontic microsurgery for 
hemostasis is reported to 0.21 - 3.75 mg (Table 2).15,16 
Therefore, approximately 3.9 - 104 times larger amount of 
epinephrine is used in endodontic microsurgery compared 
with other dental surgery or plastic surgery.
In case of systemic emergencies like anaphylaxis or 
cardiac arrest, generally 0.5 - 1.0 mg of epinephrine 
is injected intravenously to induce immediate cardiac 
excitation or assist cardiac defibrillation. Therefore, 
the amount of epinephrine we are using in endodontic 
microsurgery might be too large and its safety should be 
confirmed before application.
Cardiovascular effect of epinephrine in endodontic microsurgery
Table 1. Dose of epinephrine administered on anesthetic injection
Product 2% lidocaine with 1 : 100,000 epinephrine
2% lidocaine with 1 : 50,000 
epinephrine17,38-40
Epinephrine concentration 1 : 100,000 1 : 50,000
Epinephrine dose 0.018 mg/ample 0.036 mg/ample
Number of ample used in microsurgery 2 - 3 amples 2 - 3 amples17
Total epinephrine dose 0.036 - 0.054 mg 0.072 - 0.108 mg
Table 2. Dose of epinephrine administered on hemostasis
Product Racellet #3 CollaCote soaked in epinephrine solution (Racepinephrine)
Cotton soaked in epinephrine 
solution (Bosmin)
Epinephrine concentration 
(in effective concentration)
N/A 11.25 : 1,000 (Racepinephrine) 1 : 1,000 (Bosmin)
Epinephrine dose/pellet
(in effective concentration)
0.21 - 0.34 mg/pellet 1.05 - 1.25 mg 0.07 - 0.125 mg/cotton
Number of pellet used 
in microsurgery
1 - 7 pellets16 1 - 3 pellets15 3 - 10 cottons
Total epinephrine dose 
(in effective concentration)
0.21 - 2.38 mg16 1.05 - 3.75 mg15 0.21 - 1.25 mg
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2. Administration route of epinephrine
Most of epinephrine is applicated through intraosseous 
route in endodontic microsurgery. Therefore the systemic 
potency of intraosseous route should be compared 
with other pathways like subcutaneous, submucous, or 
intravenous routes to estimate the amount of risk.
Cancellous bone is known to be highly vascularized 
with much of capillary distribution. Wood et al. observed 
heart rate after local anesthetic injection, and compared 
intraosseous injection with infiltration injection in terms 
of heart rate change.20 Significant increase in heart rate 
was indentified in intraosseous injection compared with 
infiltration injection during injection and after 2 minutes.
Hoskins et al. used swine model to compare intraosseous 
injection with IV injection in terms of inflow capacity to 
systemic circulation as he measured aortic concentration 
of epinephrine 480 seconds after injection.21 Intraosseous 
injection through sternum resulted 86% of epinephrine 
concentration in relative dose compared with IV injection, 
and intraosseous injection via tibia showed 65% of 
epinephrine concentration compared with IV injection. 
According to this result, he suggested intraosseous 
injection of epinephrine as a second choice when IV 
injection is difficult in cardiovascular emergencies.
On the basis of these studies, we can expect that 
cardiovascular effect of intraosseous route is comparable 
to intravenous route, and stronger than subcutaneous or 
submucosal route.
Clinical studies and case reports
Two clinical studies were found, which examined 
cardiovascular effects of epinephrine during endodontic 
surgery (Table 3).15,16
Vickers et al. evaluated 17 ASA I or II patients who 
underwent endodontic surgery with the use of topical 
epinephrine for hemostasis.16 Racemic epinephrine pellets 
(Racellet #3) were applied into bone cavity to achieve 
hemostasis during surgery, and blood pressure and pulse 
rate was measured pre- and postoperatively and during the 
surgery. Results indicated that there was no significant 
change in blood pressure and pulse rate.
Vy et al. evaluated 42 patients who received topical 
epinephrine placement during endodontic surgery.15 
Racemic epinephrine was delivered with collagen sponge 
into bony crypt for hemostasis, and blood pressure and 
pulse rate was measured pre- and postoperatively and 
during the surgery. Other than slight increase of pulse rate 
on anesthetic injection, results showed no evident changes 
in blood pressure or pulse rate during surgical procedure. 
Vy et al. pointed out that epinephrine is not applied by 
injection mode, but applied topically. As topically applied 
epinephrine causes immediate local vasoconstriction of 
capillaries in bone cavity surface, there is little chance 
of large amount of epinephrine to be absorbed into the 
systemic circulation. This can be one of the reasons 
why there are rare emergency situations in the routine 
endodontic microsurgery.
Table 3. Clinical studies
Author Vickers et al. (2002)16 Vy et al. (2004)15
Subjects 17 42
Medical status ASA I or II Normal 
Treatment
Endodontic surgery 
with root-end resection & filling
Endodontic surgery
with root-end filling
Epinephrine type
Racemic epinephrine
(Racellet #3)
Racemic epinephrine
(Racepinephrine)
Collagen sponge
(Colla-cote)
Epinephrine dose
(effective concentration)
0.21 - 2.38 mg 1.05 - 3.75 mg
BP/HR recording
Before treatment (baseline)
At epinephrine application,
and 1, 5, 10 min after placement
Before dismissal
Before treatment (baseline)
After anesthetic injection
After epinephrine application 
Before dismissal
BP change No significant changes
No significant changes
during surgical procedure
PR change
No significant changes
Between groups
No significant changes
during surgical procedure
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 These clinical studies indicate that epinephrine can be 
considered as a stable hemostatic agent if it is applied in 
controlled volume, and for normal patients without severe 
systemic complications. Although existing clinical studies 
are not warning about potential systemic complication 
of epinephrine use in endodontic microsurgery, they still 
cannot guarantee that epinephrine can be used safely in 
all endodontic microsurgery cases. Only 59 patients without 
significant systemic disease were evaluated, and there is 
no data for patients with predisposing systemic diseases 
such as cardiovascular disease.
Many emergency cases during surgery induced by 
epinephrine administration have been reported in various 
fields of medical society, and most of them are related 
with predisposing cardiovascular complications or drug 
interactions (Table 4).28,29,35,41,42 Therefore epinephrine 
application should be carefully considered in such cases.
Epinephrine is a dose-sensitive drug and has narrow 
safety margin.25 It should be noticed that there are always 
hyper-responders in each drug, and such hypersensitivity 
reaction can lead to fatal result when it is related to 
cardiovascular complication like these cases.
Clinical suggestion
1. Pre-operative patient evaluation
Medical history should be thoroughly investigated to find 
out pre-existing cardiovascular disease or any possible 
drug interactions.31-34,36,37 Such patients are classified as 
high-risk group, and substitute hemostatic agent should be 
considered instead of epinephrine.
2. Dose control
Dose control of epinephrine is the first thing to do for 
risk management. It is recommended to use quantifiable 
products, and there are commercial products like Racellet 
pellets (Pascal International, Bellevue, WA, USA). One 
Racellet #3 pellet contains 0.55 mg of racemic epinephrine 
(0.275 mg in effective concentration), therefore clinician 
can easily estimate the whole epinephrine amount 
administered. To use cotton soaked in epinephrine solution 
is not an effective way in measuring epinephrine dose, 
because the solution volume absorbed to the cotton is not 
Cardiovascular effect of epinephrine in endodontic microsurgery
Table 4. Case reports of cardiovascular emergencies related with local epinephrine injection on oral & maxillofacial region
Author Sex/Age Epinephrine dose (mg)
Pre-op BP (mm Hg) 
and PR (bpm)
Post-op BP (mm Hg) 
and PR (bpm)
Additional side 
effect
Foster and Aston
(1983)35
F/55 0.12 
110/70
72
190/110
38 
F/61 0.10 
120/80
70 
200/100
32 
F/52  0.065 unknown 200/110 Cardiac arrest
F/66 0.20 
120/80
75 
210/110
100 
F/52 0.20 
120/80
62 
245/145
58 
M/58 0.04 
120/80
60 
260/150
52 
Ferry et al.
(1986)41
M/43 0.60 unknown 
134/96
106
Myocardiac infarction
Umino et al.
(1994)42
M/70  0.023
120/64 
84
106/56
104
Atrial fibrillation
Lee et al.
(2010)28
M/35  0.075
100/65 
80
135/85
92
Cardiac arrest
Kim et al.
(2011)29
F/73 unknown
110/80
70 
180/110
150
Myocardiac infarction
F/80 0.60
100/70 
60 
140/100 
80 
Myocardiac infarction
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uniform, ranging 0.07 - 0.125 mg/pellet.
Excess application should be avoided. As Kim and 
Rethnam recommended, to use only one epinephrine cotton 
followed by sterile dry cottons might be an alternative way 
in case bleeding is not severe.17
3. Patient monitoring
Electrocardiogram should be measured during endodontic 
microsurgery as well as blood pressure and pulse rate, 
because there is possibility of cardiac arrhythmia and it 
is impossible to detect it without electrocardiogram. All 
parameters must be checked in real-time to deal with 
emergency immediately.
Conclusions
The effect of epinephrine administration during 
endodontic microsurgery has not been fully investigated. 
Clinical studies to date do not provide sufficient 
information about potential systemic complications of 
epinephrine use in endodontic microsurgery, meanwhile 
case reports and case series are warning about the risk. 
Clinicians should be aware of the nature of epinephrine, 
and should pay attention to its potential risk when 
treating patient with endodontic microsurgery, especially 
for medically compromised patients.
Further research is strongly recommended to evaluate 
the cardiovascular effect of epinephrine application 
during endodontic microsurgery, and to establish 
standard guidelines that can guarantee safety of patients 
with various systemic conditions during endodontic 
microsurgery.
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